Biocat Net

Amine biocat 3.0

Interference RNA for hereditary transthyretin amyloidosis

For the first time, the FDA (the US administration responsible for approving new drugs and equivalent to the European EMA) has approved an interference RNA-based therapy to treat hereditary transthyretin amyloidosis (ATTR).ATTR is a rare disease that produces the accumulation of erroneous proteins in different organs, tissues or nerves, making it difficult to function and causing multiple symptoms that worsen the patient's quality of life.What...

What are vaccines?

This week we will talk about vaccines, something that we are all used to, but that we do not know or do not understand exactly.Would you know how to define the term vaccine, what they contain, what they are used for or what are the existing types? If not, I recommend that you continue reading.I could not write this post without telling you the curious way in which the vaccination story began. In 1768, the doctor Edwar Jenner studied the case of...

Genetically modified immunotherapy and virus to treat glioblastoma

Although therapeutic strategies based on either the use of viruses or immunotherapy have already been tested in patients, the combination of both strategies has never been tested in humans before. Genetically modified viruses and immunotherapy are to be used in patients with glioblastoma, the most aggressive brain tumor.What is glioblastoma? What is this methodology based on? What is the result of combining both therapeutic strategies?...

Prime Editing: Improving the CRISPR-Cas9 system

If we all thought that the CRISPR-Cas9 system was going to be the greatest achievement of science in the field of genetic engineering, we were wrong. Prime editing, the improved version of CRISPR, allows you to edit gene sequences in one step, and could potentially solve 90% of genetic diseases. What does it consist of? What is the difference between them? What could it be useful for? KEEP READING!I think the CRISPR-Cas9 system has been, and...